ST
JAZZ icon

Somerset Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Somerset Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-579
Closed -$83K – 136
2019
Q1 		$83K Hold
579
– – 0.04% 109
2018
Q4 		$72K Sell
579
-2,437
-81% -$362K 0.04% 111
2018
Q3 		$507K Sell
3,016
-2
-0.1% -$344 0.25% 96
2018
Q2 		$520K Sell
3,018
-49
-2% -$8.01K 0.28% 96
2018
Q1 		$463K Buy
3,067
+1
+0% +$147 0.24% 108
2017
Q4 		$412K Sell
3,066
-49
-2% -$6.8K 0.21% 112
2017
Q3 		$456K Sell
3,115
-79
-2% -$11.9K 0.24% 112
2017
Q2 		$497K Buy
3,194
+14
+0.4% +$2.14K 0.27% 107
2017
Q1 		$462K Sell
3,180
-5
-0.2% -$651 0.26% 113
2016
Q4 		$347K Sell
3,185
-103
-3% -$11.5K 0.21% 121
2016
Q3 		$400K Buy
3,288
+1
+0% +$135 0.24% 120
2016
Q2 		$464K Hold
3,287
– – 0.29% 106
2016
Q1 		$429K Sell
3,287
-33
-1% -$4.11K 0.28% 109
2015
Q4 		$467K Sell
3,320
-16
-0.5% -$2.22K 0.31% 110
2015
Q3 		$443K Buy
3,336
+198
+6% +$34.1K 0.31% 110
2015
Q2 		$552K Buy
3,138
+16
+0.5% +$2.87K 0.36% 103
2015
Q1 		$539K Buy
3,122
+39
+1% +$6.69K 0.36% 96
2014
Q4 		$505K Sell
3,083
-21
-0.7% -$3.49K 0.34% 95
2014
Q3 		$498K Buy
3,104
+208
+7% +$32K 0.35% 96
2014
Q2 		$426K Sell
2,896
-1,574
-35% -$218K 0.3% 100
2014
Q1 		$620K Sell
4,470
-10
-0.2% -$1.5K 0.47% 81
2013
Q4 		$567K Buy
+4,480
New +$464K 0.43% 82

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Somerset Trust's JAZZ Position: Q2 2019 in Review

Somerset Trust sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2019, closing a stake of 579 shares — an estimated $83K sold.

Somerset Trust first reported a position in JAZZ in Q4 2013 and held it in 22 quarters. The position peaked at $620K in Q1 2014. 416 funds tracked by Wall St. Rank hold JAZZ as of Q2 2019.

  • Somerset Trust reported no remaining Jazz Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Somerset Trust sold 579 Jazz Pharmaceuticals shares in Q2 2019, an estimated $83K.
  • Somerset Trust first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 22 quarters.
  • Somerset Trust's Jazz Pharmaceuticals position peaked at $620K in Q1 2014.
  • 416 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2019.

Based on Somerset Trust's 13F filing for Q2 2019, filed 31 Jul 2019.